Modulation of chondrocyte proteoglycan synthesis by endogeneously produced nitric oxide.
Stefanovic-Racic
M
M
Ferguson Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, School of Medicine, PA 15261, USA.
Taskiran
D
D
Georgescu
H I
HI
Evans
C H
CH
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001345:Autoradiography; D002358:Cartilage, Articular / Q000166:cytology / Q000378:metabolism*; D015232:Dinoprostone / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D004791:Enzyme Inhibitors / Q000494:pharmacology; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000494:pharmacology; D009569:Nitric Oxide / Q000096:biosynthesis / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D010396:Penicillamine / Q000031:analogs & derivatives / Q000494:pharmacology; D011509:Proteoglycans / Q000096:biosynthesis*; D011817:Rabbits; D026423:S-Nitroso-N-Acetylpenicillamine; D014665:Vasodilator Agents / Q000494:pharmacology; D019323:omega-N-Methylarginine
D004791:Enzyme Inhibitors; D007375:Interleukin-1; D011509:Proteoglycans; D014665:Vasodilator Agents; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D026423:S-Nitroso-N-Acetylpenicillamine; D001120:Arginine; D019001:Nitric Oxide Synthase; D010396:Penicillamine; D015232:Dinoprostone